Screener
Myriad Genetics MYGN Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Revenue | $200.4 | $195.9 |
| Cost of revenue | 62.8 | 61.7 |
| Gross profit | 137.6 | 134.2 |
| Costs and expenses: | ||
| Research and development expense | 27.1 | 27.5 |
| Sales and marketing expense | 73.6 | 69.2 |
| General and administrative expense | 62.2 | 66.5 |
| Goodwill and long-lived asset impairment charges | 5.4 | — |
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's total revenue?
- Myriad Genetics (MYGN) reported total revenue of $200.4M in Q1 2026.
- How has Myriad Genetics's total revenue changed year-over-year?
- Myriad Genetics's total revenue increased by 2.3% year-over-year, from $195.9M to $200.4M.
- What is the long-term trend for Myriad Genetics's total revenue?
- Over 4 years (2021 to 2025), Myriad Genetics's total revenue has grown at a 4.5% compound annual growth rate (CAGR), from $690.6M to $824.5M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Myriad Genetics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude